This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Plan chromogenic CLOCK IHC in paraffin sections around the nuclear tissue staining reported by HPA (HPA tissue IHC). Consider collection time when comparing samples, because CLOCK shuttles between nucleus and cytoplasm under circadian and BMAL1-dependent control (UniProt).
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected localisation | Predominantly nuclear tissue staining (HPA tissue IHC); cytoplasmic shuttling is possible (UniProt) | |
| Staining pattern | Nuclear staining across tissues; high in testis Leydig cells (HPA tissue IHC) | |
| Antigen retrieval | Tris-EDTA pH 9.0 HIER, 95–98 °C, 20 min (rule: nuclear antigen) | |
| Positive control | Testis+4 more · see all | |
| Negative control | None in HPA (detected in all 45 tissues); use no-primary + isotype controls |
| Fixation | Keep fixation consistent across samples. (standard IHC practice; not target-specific) | |
| Caveat | Circadian phase may shift nuclear versus cytoplasmic signal (UniProt) | |
| Regulation | BMAL1-dependent circadian shuttling (UniProt) | |
| Isoform / epitope | No annotated isoforms; one chain spans residues 1–846 (UniProt) |
The catalog antibody’s IHC-P protocol is followed by four published CLOCK IHC methods, covering frozen vascular sections and paraffin-embedded bone and liver sections (PMC6085090; PMC5765856; PMC9098081; PMC5985434).
| Sample | Paraffin-embedded human thyroid carcinoma tissue; fixative not specified (datasheet M00064) |
| Fixation | Image fixative and duration unreported (datasheet M00064); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat-induced epitope retrieval in Tris-EDTA buffer, pH 9.0, 20 min at 95–98 °C (standard rule: nuclear antigen) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% normal serum of the secondary host, 30 min, room temperature (standard) |
| Primary antibody | Rabbit monoclonal (clone ACCH-3) anti-CLOCK, 1:50 (datasheet M00064) |
| Primary incubation | Overnight at 4 °C (standard) |
| Detection | HRP-polymer secondary, DAB chromogen 5–10 min (standard) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | CLOCK-positive staining in leydig cells of testis (HPA tissue IHC: High). HPA tissue profile: Ubiquitous nuclear expression. No signal in the no-primary control. |
CLOCK is chiefly nuclear in tissue IHC, with a ubiquitous nuclear pattern rated Supported by HPA; that rating reflects medium consistency between staining and RNA data (HPA: tissue IHC). Expect especially strong staining in testicular Leydig cells, with staining also reported in several other cell types (HPA: High in Leydig cells; Medium in listed tissues). Cytoplasmic staining can occur because CLOCK shuttles between cytoplasm and nucleus (UniProt O15516: subcellular location); CLOCK has no transmembrane segment (UniProt O15516: topology).
| Distinct nuclear chromogen in Leydig cells, with weaker nuclear staining in other tissues (HPA: tissue IHC). | This fits the reported ubiquitous nuclear pattern and High Leydig cell staining. Compare intensity within the same run; HPA levels are observational categories, not a quantitative calibration (HPA: tissue IHC). |
| Predominantly cytoplasmic staining with little nuclear signal in an otherwise positive section (HPA: ubiquitous nuclear IHC pattern). | Treat a persistent compartment mismatch as a possible staining artefact and check controls. Do not reject every cytoplasmic signal: CLOCK shuttles, and its nonphosphorylated form is reported in the cytoplasm (UniProt O15516: subcellular location). |
| Strong staining in cells outside the reported HPA pattern, especially when expected nuclei are unstained (HPA: tissue IHC). | Consider antibody cross-reactivity or endogenous chromogenic activity. Compare morphology and a no-primary control before assigning the signal to CLOCK (general IHC practice). HPA's listed cells do not define an exhaustive set of positive cell types (HPA: tissue IHC). |
| Diffuse chromogen covers tissue or obscures nuclear borders, including low-staining areas (HPA: Low in listed cells). | The distribution cannot be scored reliably against HPA's nuclear pattern (HPA: tissue IHC). Background may reflect nonspecific binding, incomplete blocking, or detection chemistry; assess it with no-primary and reagent controls (general IHC practice). |
| No nuclear signal in testicular Leydig cells (HPA: High in Leydig cells). | First suspect an uninformative run, then check section identity, tissue preservation, retrieval, antibody and detection controls (general IHC practice). One negative section cannot overturn a pattern HPA rates Supported with medium RNA consistency (HPA: tissue IHC). |
| Cell type and tissue selection | Leydig cells offer a reported High IHC signal; adipocytes and several listed glandular or neuronal cells are Medium, while listed low-staining cells are weak comparators, not true negatives (HPA: tissue IHC). |
| Cellular distribution and sampling time | CLOCK shuttling is circadian regulated and BMAL1 dependent; nuclear and cytoplasmic proportions may differ across samples (UniProt O15516: subcellular location). Record collection time when comparing groups (general experimental practice). |
| Protein form and epitope claims | UniProt lists one chain spanning residues 1–846, no signal peptide or propeptide, and several phosphorylation sites (UniProt O15516: processing and modified residues). These facts do not identify this antibody's epitope or establish a retrieval condition. |
| Antibody evidence | Two listed antibodies, HPA001867 and HPA027565, have Supported IHC and ICC status (HPA: antibody validation). HPA calls the tissue pattern Supported with medium RNA consistency; neither statement establishes performance for every specimen (HPA: tissue IHC). |
| IF/ICC Q&A: what location should fluorescence show? | Mainly nucleoplasmic signal, with additional vesicular localization reported in ICC-IF (HPA: subcellular, supported nucleoplasm; approved vesicles). UniProt also reports cytoplasmic localization and regulated shuttling (UniProt O15516: subcellular location). |
| Situation | Likely cause | Next action |
|---|---|---|
| Leydig cell nuclei are blank in the testis reference section (HPA: High in Leydig cells). | The run may have failed at retrieval, primary incubation, or detection; the HPA observation alone cannot identify which step (HPA: tissue IHC; general IHC practice). | Verify section identity and morphology, then review the IHC-validated antibody's instructions and run a known-positive control beside the sample (general IHC practice). |
| Chromogen is mainly cytoplasmic throughout a section expected to show nuclear staining (HPA: ubiquitous nuclear pattern). | Background or a staining artefact is possible, though cytoplasmic CLOCK is biologically plausible (UniProt O15516: subcellular location). | Check nuclear counterstain and no-primary control; assess whether cytoplasmic signal is cell bounded and reproducible before interpreting localization (general IHC practice). |
| Strong color appears in an unexpected cell population (HPA: tissue IHC). | Cross-reactivity or endogenous detection activity may mimic staining; HPA's listed observations cannot settle the identity of every stained cell (HPA: tissue IHC; general IHC practice). | Compare morphology, no-primary and detection-only controls, and the expected nuclear distribution; investigate persistent signal with an independently validated antibody if available (general IHC practice). |
| Background obscures nuclei across the section (HPA: nuclear tissue pattern). | Nonspecific primary or secondary binding, insufficient blocking, or chromogen development may contribute (general IHC practice). | Check no-primary background, blocking and wash steps; adjust detection or primary conditions using the IHC-validated antibody's instructions (general IHC practice). |
| A low-staining comparison tissue shows no visible CLOCK signal (HPA: Low in listed cells). | A Low HPA category can fall below the run's visual threshold; it is not a documented negative control (HPA: tissue IHC). | Judge assay performance using a reported High reference such as Leydig cells, while retaining the low-staining section as a distribution comparison (HPA: High in Leydig cells; Low in listed cells). |
| Nuclear intensity differs between otherwise comparable specimens (HPA: ubiquitous nuclear pattern). | Regulated cytoplasm-to-nucleus shuttling is one biological possibility; technical variation is another (UniProt O15516: subcellular location; general IHC practice). | Record collection times, stain comparison sections together, and score nuclear signal with the same criteria and controls (general experimental and IHC practice). |
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Supported — Medium consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Testis | Leydig cells | High | Protein (IHC) | HPA → |
| Adipose tissue | Adipocytes | Medium | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Medium | Protein (IHC) | HPA → |
| Appendix | Glandular cells | Medium | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| None in HPA: CLOCK is detected in all 45 scored tissues. Use a no-primary (secondary-only) and an isotype control instead. | ||||
Troubleshoot CLOCK staining in paraffin sections by checking retrieval, nuclear localisation, controls and scoring before interpreting biological differences.
Anti-CLOCK IHC images show paraffin sections of human thyroid carcinoma, human cancer tissue, and mouse and rat brain (M00064 and RP1082 IHC captions); IF images show HeLa and U2OS cells (M00064 and RP1082 IF captions).
M00064 will render with an IHC image of a paraffin-embedded human thyroid carcinoma section (M00064 IHC caption). Its catalog also lists IF/ICC, with an IF image of HeLa cells (M00064 applications and IF caption).
Which to pick: For tissue IHC, M00064 has a human paraffin-section image; RP1082 adds documented mouse and rat brain paraffin-section images and a 2 μg/ml staining example (M00064 IHC caption; RP1082 IHC captions). For IF/ICC, both list the application and show cell images: HeLa for M00064 and U2OS for RP1082 (M00064 and RP1082 applications and IF captions). For cross-species tissue IHC, RP1082 has the stronger image evidence; M00064 lists human, mouse and rat reactivity but shows only human tissue, and neither SKU’s IHC caption reports a fixative (RP1082 IHC captions; M00064 reactivity and IHC caption).